Community Engagement in Practice - Small Group Discussions

Improving clinical trial diversity is a shared goal with, perhaps, different motivations for different stakeholders, including but not limited to: ensuring safety and efficacy of medical products in all people who will use them; health justice; meeting regulatory requirements; and securing funding. Regardless of the “why,” communication, relationship building with underrepresented communities, and sustainable partnerships are paramount for making progress toward this goal. Participants will discuss a scenario in groups at roundtables and report out challenges, solutions, and strategies.